Company intelligence / Profile preview
Akrocell Biosciences
Seoul, Seoul, South Koreaakrocell.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Akrocell Biosciences develops cutting-edge tissue regeneration treatments and solutions using proprietary tissue structure formation and biocompatible material technologies. The company has secured several patents and awards for innovation but has not yet reported clinical results or advanced to human trials.
- Therapeutic areas
- OtherCardiovascular
- Modalities
- Tissue engineeringorganoidsbiocompatible materials
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Selected as an incubating startup by Seoul St. Mary’s Hospital (‘Bio Core Facility’ program)
Beyond the preview
Go deeper on Akrocell Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Akrocell Biosciences.